This result is also supported by previous studies, in which colonic epithelial GAD67 inhibited the release of the proinflammatory factor TNF-α and alleviated inflammation-mediated intestinal motility disorders (Kinoshita et al., 2006; Younis et al., 2024). The gene discussed is GAD1; the disease is intestinal motility disease.